Exact Mass: 331.2126

Exact Mass Matches: 331.2126

Found 138 metabolites which its exact mass value is equals to given mass value 331.2126, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

2-[Octahydro-4,7-dimethyl-1-oxocyclopenta[c]pyran-3-yl]nepetalactam

2-{4,7-dimethyl-1-oxo-octahydrocyclopenta[c]pyran-3-yl}-4,7-dimethyl-1H,2H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyridin-1-one

C20H29NO3 (331.2147)


2-[Octahydro-4,7-dimethyl-1-oxocyclopenta[c]pyran-3-yl]nepetalactam is found in herbs and spices. 2-[Octahydro-4,7-dimethyl-1-oxocyclopenta[c]pyran-3-yl]nepetalactam is isolated from a commercial sample of catnip oil (Nepeta cataria). Isolated from a commercial sample of catnip oil (Nepeta cataria). 2-[Octahydro-4,7-dimethyl-1-oxocyclopenta[c]pyran-3-yl]nepetalactam is found in tea and herbs and spices.

   

Marimastat

(2S,3R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N,2-dihydroxy-3-(2-methylpropyl)butanediamide

C15H29N3O5 (331.2107)


Marimastat is only found in individuals that have used or taken this drug. It is used in the treatment of cancer, Marmiastat is an angiogenesis and metastasis inhibitor. As an angiogenesis inhibitor it limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes.Marimastat is a broad spectrum matrix metalloprotease inhibitor. It mimics the peptide structure of natural MMP substrates and binds to matrix metalloproteases, thereby preventing the degradation of the basement membrane by these proteases. This antiprotease action prevents the migration of endothelial cells needed to form new blood vessels. Inhibition of MMPs also prevents the entry and exit of tumor cells into existing blood cells, thereby preventing metastasis. C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D004791 - Enzyme Inhibitors

   

N-Lauroyl Methionine

2-[(1-Hydroxydodecylidene)amino]-4-(methylsulphanyl)butanoic acid

C17H33NO3S (331.2181)


N-lauroyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Methionine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Myristoyl Cysteine

3-sulfanyl-2-tetradecanamidopropanoic acid

C17H33NO3S (331.2181)


N-myristoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

2H-1,2-Oxazin-3(4H)-one, 4-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)dihydro-2-methyl-

2H-1,2-Oxazin-3(4H)-one, 4-((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methylene)dihydro-2-methyl-

C20H29NO3 (331.2147)


   

Centhaquine

2-{2-[4-(3-methylphenyl)piperazin-1-yl]ethyl}quinoline

C22H25N3 (331.2048)


   

N-Methoxy-3-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2-pyrrolidone

3-[(3,5-di-tert-butyl-4-hydroxyphenyl)methylidene]-1-methoxypyrrolidin-2-one

C20H29NO3 (331.2147)


   

Tricalysiamide B

Tricalysiamide B

C20H29NO3 (331.2147)


   

Echinophyllin F

Echinophyllin F

C20H29NO3 (331.2147)


   

Echinophyllin C

Echinophyllin C

C20H29NO3 (331.2147)


   

19-O-deethyl spiramine N

19-O-deethyl spiramine N

C20H29NO3 (331.2147)


   

1,2-Dihydrocomosidine

1,2-Dihydrocomosidine

C20H29NO3 (331.2147)


   

jatrophalactam A

jatrophalactam A

C20H29NO3 (331.2147)


   

cespitulactam I

cespitulactam I

C20H29NO3 (331.2147)


   
   

(8E)-N-isobutyl-9-(3,4-methylenedioxyphenyl)nona-8-enamide|dehydroretrofractamide C

(8E)-N-isobutyl-9-(3,4-methylenedioxyphenyl)nona-8-enamide|dehydroretrofractamide C

C20H29NO3 (331.2147)


   

O-Methyltaxodine

O-Methyltaxodine

C20H29NO3 (331.2147)


   
   

lysylglycyllysine

lysylglycyllysine

C14H29N5O4 (331.2219)


   
   
   
   
   
   
   
   
   
   
   

SCHEMBL11567542

SCHEMBL11567542

C15H29N3O5 (331.2107)


   

glycyllysyllysine

glycyllysyllysine

C14H29N5O4 (331.2219)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Marimastat

(2S,3R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N,2-dihydroxy-3-(2-methylpropyl)butanediamide

C15H29N3O5 (331.2107)


C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D004791 - Enzyme Inhibitors

   

2-[Octahydro-4,7-dimethyl-1-oxocyclopenta[c]pyran-3-yl]nepetalactam

2-{4,7-dimethyl-1-oxo-octahydrocyclopenta[c]pyran-3-yl}-4,7-dimethyl-1H,2H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyridin-1-one

C20H29NO3 (331.2147)


   

1-(4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)PIPERAZIN-1-YL)ETHANONE

1-(4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)PIPERAZIN-1-YL)ETHANONE

C17H26BN3O3 (331.2067)


   

2,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H27B2NO4 (331.2126)


   

3,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

3,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H27B2NO4 (331.2126)


   

(2S,4R)-1-Boc-4-(tert-butyldimethylsilyloxy)-2-(hydroxyMethyl)pyrrolidine

(2S,4R)-1-Boc-4-(tert-butyldimethylsilyloxy)-2-(hydroxyMethyl)pyrrolidine

C16H33NO4Si (331.2179)


   

Acetamide, N-[1-[tris(1-methylethyl)silyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-

Acetamide, N-[1-[tris(1-methylethyl)silyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-

C18H29N3OSi (331.208)


   
   

Methyl 3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxylate

Methyl 3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxylate

C20H29NO3 (331.2147)


   
   

(1-methylpiperidin-3-yl) 2-cyclohexyl-2-hydroxy-2-phenylacetate

(1-methylpiperidin-3-yl) 2-cyclohexyl-2-hydroxy-2-phenylacetate

C20H29NO3 (331.2147)


   

Undecylenoyl Phenylalanine

Undecylenoyl Phenylalanine

C20H29NO3 (331.2147)


   

2-ethylhexan-1-amine,furan-2,5-dione,styrene

2-ethylhexan-1-amine,furan-2,5-dione,styrene

C20H29NO3 (331.2147)


   

Colestyramine

Colestyramine

C21H30ClN (331.2067)


   

(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid

(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid

C20H29NO3 (331.2147)


   

Centhaquine

Centhaquine

C22H25N3 (331.2048)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-(Dodecanoylamino)-4-methylsulfanylbutanoic acid

2-(Dodecanoylamino)-4-methylsulfanylbutanoic acid

C17H33NO3S (331.2181)


   

2-phenyl-N-(2-piperidin-1-ylethyl)quinolin-4-amine

2-phenyl-N-(2-piperidin-1-ylethyl)quinolin-4-amine

C22H25N3 (331.2048)


   

(2S)-6-amino-2-[[2-[[(2S)-2,6-diaminohexanoyl]amino]acetyl]amino]hexanoic Acid

(2S)-6-amino-2-[[2-[[(2S)-2,6-diaminohexanoyl]amino]acetyl]amino]hexanoic Acid

C14H29N5O4 (331.2219)


   

H-Ser-Leu-Leu-OH

H-Ser-Leu-Leu-OH

C15H29N3O5 (331.2107)


   
   

(2S,3S,8S,9S)-3-Amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid

(2S,3S,8S,9S)-3-Amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid

C20H29NO3 (331.2147)


   

(3Z)-3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1-methoxypyrrolidin-2-one

(3Z)-3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1-methoxypyrrolidin-2-one

C20H29NO3 (331.2147)


   

(4Z)-4-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-2-methyloxazinan-3-one

(4Z)-4-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-2-methyloxazinan-3-one

C20H29NO3 (331.2147)


   

(8E)-N-isobutyl-9-(3,4-methylenedioxyphenyl)nona-8-enamide

(8E)-N-isobutyl-9-(3,4-methylenedioxyphenyl)nona-8-enamide

C20H29NO3 (331.2147)


A natural product found in Piper boehmeriaefolium.

   
   

Leu-Leu-Ser

Leu-Leu-Ser

C15H29N3O5 (331.2107)


A tripeptide composed of two L-leucine units and L-serine joined in sequence by peptide linkages.

   

Propenzolate

Propenzolate

C20H29NO3 (331.2147)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

1-(3,4-Dimethylphenyl)-4-(4-methylpiperidin-1-yl)phthalazine

1-(3,4-Dimethylphenyl)-4-(4-methylpiperidin-1-yl)phthalazine

C22H25N3 (331.2048)


   

1-[[3-(2-Fluorophenyl)-1-methyl-4-pyrazolyl]methyl]-3-propoxypiperidine

1-[[3-(2-Fluorophenyl)-1-methyl-4-pyrazolyl]methyl]-3-propoxypiperidine

C19H26FN3O (331.206)


   

4-Anilino-4-oxobutanoic acid (4-tert-butylcyclohexyl) ester

4-Anilino-4-oxobutanoic acid (4-tert-butylcyclohexyl) ester

C20H29NO3 (331.2147)


   
   
   

Lysyl-lysyl-glycine

Lysyl-lysyl-glycine

C14H29N5O4 (331.2219)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]undecanoate

11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]undecanoate

C17H31O6- (331.2121)


   

(10R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyundecanoate

(10R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyundecanoate

C17H31O6- (331.2121)


   

oscr#18(1-)

oscr#18(1-)

C17H31O6 (331.2121)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#18, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   
   
   
   
   

(3r,5r,7s,10s,11e,13s)-10,15-dihydroxy-3,6,6,10,16-pentamethyl-14-azatricyclo[11.2.1.0⁵,⁷]hexadeca-1(16),11,14-trien-2-one

(3r,5r,7s,10s,11e,13s)-10,15-dihydroxy-3,6,6,10,16-pentamethyl-14-azatricyclo[11.2.1.0⁵,⁷]hexadeca-1(16),11,14-trien-2-one

C20H29NO3 (331.2147)


   

5-[2-(5-hydroxy-2h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

5-[2-(5-hydroxy-2h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C20H29NO3 (331.2147)


   

(1r,2s,4s,6s,7r,8r,10s,11r,12r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-ene-6,8,12-triol

(1r,2s,4s,6s,7r,8r,10s,11r,12r)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-ene-6,8,12-triol

C20H29NO3 (331.2147)


   

(1s,3s,5r,8r,9s,10s,11r,14s,17r,18r,19s)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

(1s,3s,5r,8r,9s,10s,11r,14s,17r,18r,19s)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

C20H29NO3 (331.2147)


   

(4ar,5s,6r,8ar)-5-[2-(5-hydroxy-2h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(4ar,5s,6r,8ar)-5-[2-(5-hydroxy-2h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C20H29NO3 (331.2147)


   

(1s,4s,9r,12s,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

(1s,4s,9r,12s,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C20H29NO3 (331.2147)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-hydroxypropanoic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-hydroxypropanoic acid

C15H29N3O5 (331.2107)


   

14,16-dihydroxy-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-dien-5-one

14,16-dihydroxy-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-dien-5-one

C20H29NO3 (331.2147)


   

(8e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)non-8-enimidic acid

(8e)-9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)non-8-enimidic acid

C20H29NO3 (331.2147)


   

3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-1,5,14-triol

3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-1,5,14-triol

C20H29NO3 (331.2147)


   

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C20H29NO3 (331.2147)


   

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)non-8-enimidic acid

9-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)non-8-enimidic acid

C20H29NO3 (331.2147)


   

5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,19-triol

C20H29NO3 (331.2147)


   

5-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

5-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C20H29NO3 (331.2147)


   

(4as,5r,6s,8as)-5-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(4as,5r,6s,8as)-5-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C20H29NO3 (331.2147)


   

(4as,5r,6s,8as)-5-[2-(5-hydroxy-2h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(4as,5r,6s,8as)-5-[2-(5-hydroxy-2h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C20H29NO3 (331.2147)


   

(1z,3s,10s,13r,16s)-14,16-dihydroxy-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-dien-5-one

(1z,3s,10s,13r,16s)-14,16-dihydroxy-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-dien-5-one

C20H29NO3 (331.2147)


   

(4ar,5s,6r,8ar)-5-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(4ar,5s,6r,8ar)-5-[2-(2-hydroxy-5h-pyrrol-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C20H29NO3 (331.2147)


   

(1s,4s,9r,12s,13s,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

(1s,4s,9r,12s,13s,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C20H29NO3 (331.2147)


   

10,15-dihydroxy-3,6,6,10,16-pentamethyl-14-azatricyclo[11.2.1.0⁵,⁷]hexadeca-1(16),11,14-trien-2-one

10,15-dihydroxy-3,6,6,10,16-pentamethyl-14-azatricyclo[11.2.1.0⁵,⁷]hexadeca-1(16),11,14-trien-2-one

C20H29NO3 (331.2147)


   

(1s,3e,5s,10r)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-1,5,14-triol

(1s,3e,5s,10r)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16),14-triene-1,5,14-triol

C20H29NO3 (331.2147)